|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2005
Risk factors of frequent exacerbations in difficult-to-treat asthma
Depts of 2 Pulmonary Diseases, 3 Gastro-enterology and Hepatology, and 4 Psychology, Leiden University, Leiden, 5 Dept of Otorhinolaryngology, Ziekenhuis Amstelland, Amstelveen, 6 Dept of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, and 1 Dept of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
CORRESPONDENCE: E. H. Bel, Dept of Pulmonary Diseases, C3-P, Leiden University Medical Center, P.O. Box 9600, NL-2300 RC Leiden, The Netherlands. Fax: 31 715154691. E-mail: E.H.D.Bel{at}lumc.nl
Keywords: Asthma, asthma exacerbations, gastro-oesophageal reflux, psychology, sinusitis
Received: March 30, 2005
Accepted August 5, 2005
Recurrent exacerbations are a major cause of morbidity and medical expenditure in patients with asthma. Various exogenous and endogenous factors are thought to influence the level of asthma control, but systematical data on the involvement of these factors in the recurrence of asthma exacerbations are scarce.
In this study, 13 clinical and environmental factors potentially associated with recurrent exacerbations were investigated in 136 patients with difficult-to-treat asthma. Patients with more than three severe exacerbations (n = 39) in the previous year were compared with those with only one exacerbation per year (n = 24). A systematic diagnostic protocol was used to assess 13 potential risk factors.
Factors significantly associated with frequent exacerbations included: severe nasal sinus disease (adjusted odds ratio (OR) 3.7); gastro-oesophageal reflux (OR 4.9); recurrent respiratory infections (OR 6.9); psychological dysfunctioning (OR 10.8); and obstructive sleep apnoea (OR 3.4). Severe chronic sinus disease and psychological dysfunctioning were the only independently associated factors (adjusted OR 5.5 and 11.7, respectively). All patients with frequent exacerbations exhibited at least one of these five factors, whilst 52% showed three or more factors.
In conclusion, the results show that recurrent exacerbations in asthma are associated with specific co-morbid factors that are easy to detect and that are treatable. Therapeutic interventions aimed at correcting these factors are likely to reduce morbidity and medical expenditure in these patients.
This article has been cited by other articles:
|
|
 |
|
  H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gaga, E. Zervas, and P. Chanez Update on severe asthma: what we know and what we need Eur. Respir. Rev., June 1, 2009; 18(112): 58 - 65. [Full Text] [PDF]
|
|
|
|
 |
|
 K Terada, S Muro, S Sato, T Ohara, A Haruna, S Marumo, D Kinose, E Ogawa, Y Hoshino, A Niimi, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation Thorax, November 1, 2008; 63(11): 951 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur. Respir. J., August 1, 2008; 32(2): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thorsteinsdottir, G. W. Volcheck, B. E. Madsen, A. M. Patel, J. T. C. Li, and K. G. Lim The ABCs of Asthma Control Mayo Clin. Proc., July 1, 2008; 83(7): 814 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zervas, E. Oikonomidou, E. Kainis, M. Kokkala, K. Petroheilou, and M. Gaga Review: Control of asthma Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 141 - 148. [Abstract] [PDF]
|
|
|
|
 |
|
 R C Reddy Severe asthma: approach and management Postgrad. Med. J., March 1, 2008; 84(989): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Weiner, A. Schwartz, R. Yudkowsky, G. D. Schiff, F. M. Weaver, J. Goldberg, and K. B. Weiss Evaluating Physician Performance at Individualizing Care: A Pilot Study Tracking Contextual Errors in Medical Decision Making Med Decis Making, December 1, 2007; 27(6): 726 - 734. [Abstract] [PDF]
|
|
|
|
|
|
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri Update in Chronic Obstructive Pulmonary Disease 2006 Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232. [Full Text] [PDF]
|
|
|
|
|
|
IlonkaH. van Veen, PieterS. Hiemstra, A. ten Brinke, A. Roos, RenateM. Verhoosel, JaapK. Sont, PeterJ. Sterk, KlausF. Rabe, and ElisabethH. Bel Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Eur. Respir. Rev., December 1, 2006; 15(101): 224 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chanez and P. Godard Is difficult asthma still clinically meaningful? Eur. Respir. J., November 1, 2006; 28(5): 897 - 899. [Full Text] [PDF]
|
|
|
|
|
|
J M FitzGerald and P G Gibson Asthma exacerbations {middle dot} 4: Prevention. Thorax, November 1, 2006; 61(11): 992 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Caramori, A. Papi, A. Mutgi, J. Hammersley, Y. Kuramochi, T. Morita, R. Osawa, R. Andraws, S. L. Johnston, R. B. Nieman, et al. Telithromycin in acute exacerbations of asthma. N. Engl. J. Med., July 6, 2006; 355(1): 96 - 97. [Full Text] [PDF]
|
|
|
|
|
|
C. Butler and L. G. Heaney Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur. Respir. J., June 1, 2006; 27(6): 1324 - 1325. [Full Text] [PDF]
|
|
|
|
|
|
A. ten Brinke and E. H. Bel From the authors Eur. Respir. J., June 1, 2006; 27(6): 1325 - 1326. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |